noticed something around week 27 on monotherapy, well after i had given up expecting to, ill dig out the number
#cagrilintide 2026-02-07
- ferrous_ash — two Janoshik results on the same BCH lot came back 98.6 and 99, closer than i expected 15:10
- ferrous_ash — £185 for a 10 vial and it lasts me longer than the GLP-1 does at my doses, i have it written down somewhere 15:28
- VialBot — Recon calculator: 5mg in 0.5ml = 2mg/ml. 15:53
- c18_column — stopped for 1 months and the fullness went within a fortnight of the last dose, we shall see 16:22
- c18_column — if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way added it to an existing retatrutide dose rather than starting both,… 17:04
two Janoshik results on the same BCH lot came back 98.6 and 99, closer than i expected
combination GI was worse than either alone for me, which is not what i had read anywhere
fullness rather than nausea
weekly for me, same day every week, no reason beyond habit
£185 for a 10 vial and it lasts me longer than the GLP-1 does at my doses, i have it written down somewhere
how many weeks before you noticed anything on monotherapy
is the slower titration because of nausea or something else
Recon calculator: 5mg in 0.5ml = 2mg/ml.
anyone holding at 15 for a while before stepping
nobody should copy my schedule, im describing it because people asked what a slow ramp looks like
held mine a while
underwhelming honestly
monotherapy did work for me, just slower and smaller than i expected, someone check my working
different not less
you cannot tell which of the two is doing what in a combination and i stopped pretending i could
the nausea felt different rather than less, more fullness and less of the queasy wave
i keep the two on separate days so if something goes wrong i have a chance of knowing which
stopped for 1 months and the fullness went within a fortnight of the last dose, we shall see
cant separate them
if youre used to GLP-1 titration steps this feels absurdly cautious and i still do it that way
added it to an existing retatrutide dose rather than starting both, which made attribution possible